This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-27a-3p | A1CF | -0.37 | 0.00876 | -0.98 | 1.0E-5 | MirTarget | -0.55 | 0 | NA | |
2 | hsa-miR-27a-3p | ABAT | -0.37 | 0.00876 | -2.16 | 0 | MirTarget | -0.5 | 0 | NA | |
3 | hsa-miR-27a-3p | ABCA1 | -0.37 | 0.00876 | -1.1 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.15 | 0.00176 | NA | |
4 | hsa-miR-27a-3p | ABHD6 | -0.37 | 0.00876 | -1.31 | 0 | miRNATAP | -0.41 | 0 | NA | |
5 | hsa-miR-27a-3p | AGGF1 | -0.37 | 0.00876 | 0.14 | 0.03026 | miRNATAP | -0.12 | 0 | 24462738 | Role of microRNA 27a in down regulation of angiogenic factor AGGF1 under hypoxia associated with high grade bladder urothelial carcinoma; Hypoxia-induced down-regulation of AGGF1 was mediated by miR-27a; Overexpression of miR-27a suppressed AGGF1 expression through translational inhibition but not by RNA degradation; Moreover the hypoxia-induced decrease of AGGF1 expression disappeared after miR-27a expression was inhibited |
6 | hsa-miR-27a-3p | AGPAT3 | -0.37 | 0.00876 | -0.18 | 0.05507 | miRNATAP | -0.14 | 1.0E-5 | NA | |
7 | hsa-miR-27a-3p | AKIRIN2 | -0.37 | 0.00876 | -0.26 | 0.00807 | miRNATAP | -0.12 | 0.00021 | NA | |
8 | hsa-miR-27a-3p | ALCAM | -0.37 | 0.00876 | 0.24 | 0.05364 | MirTarget | -0.16 | 0.00029 | NA | |
9 | hsa-miR-27a-3p | ALDH9A1 | -0.37 | 0.00876 | -1.02 | 0 | miRNAWalker2 validate | -0.22 | 0 | NA | |
10 | hsa-miR-27a-3p | ALG9 | -0.37 | 0.00876 | 0.16 | 0.03963 | MirTarget | -0.12 | 0 | NA | |
11 | hsa-miR-27a-3p | APOOL | -0.37 | 0.00876 | -0.42 | 0.00899 | MirTarget | -0.11 | 0.04681 | NA | |
12 | hsa-miR-27a-3p | AQP11 | -0.37 | 0.00876 | -0.63 | 0.00064 | MirTarget; miRNATAP | -0.58 | 0 | NA | |
13 | hsa-miR-27a-3p | ARHGAP32 | -0.37 | 0.00876 | -0.2 | 0.09921 | mirMAP | -0.11 | 0.00903 | NA | |
14 | hsa-miR-27a-3p | ARID4A | -0.37 | 0.00876 | -0.9 | 0 | miRNATAP | -0.11 | 0.00891 | NA | |
15 | hsa-miR-27a-3p | ARIH2 | -0.37 | 0.00876 | 0.34 | 0 | miRNATAP | -0.11 | 0 | NA | |
16 | hsa-miR-27a-3p | ARL4D | -0.37 | 0.00876 | -0.85 | 2.0E-5 | miRNATAP | -0.45 | 0 | NA | |
17 | hsa-miR-27a-3p | ARL6IP1 | -0.37 | 0.00876 | -0.85 | 0 | miRNAWalker2 validate | -0.11 | 0.00302 | NA | |
18 | hsa-miR-27a-3p | ARNTL | -0.37 | 0.00876 | -0.35 | 0.02331 | miRNATAP | -0.2 | 0.00018 | NA | |
19 | hsa-miR-27a-3p | ATP7B | -0.37 | 0.00876 | -0.73 | 2.0E-5 | miRNAWalker2 validate | -0.41 | 0 | NA | |
20 | hsa-miR-27a-3p | BMI1 | -0.37 | 0.00876 | 0.21 | 0.02579 | miRNAWalker2 validate | -0.18 | 0 | NA | |
21 | hsa-miR-27a-3p | BRPF3 | -0.37 | 0.00876 | 0.35 | 0.00299 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
22 | hsa-miR-27a-3p | BRWD3 | -0.37 | 0.00876 | 0.1 | 0.5367 | MirTarget; miRNATAP | -0.13 | 0.01423 | NA | |
23 | hsa-miR-27a-3p | BSN | -0.37 | 0.00876 | 0.94 | 2.0E-5 | mirMAP | -0.49 | 0 | NA | |
24 | hsa-miR-27a-3p | C16orf52 | -0.37 | 0.00876 | -0.5 | 0 | miRNATAP | -0.15 | 2.0E-5 | NA | |
25 | hsa-miR-27a-3p | CABLES2 | -0.37 | 0.00876 | 0.82 | 0 | miRNATAP | -0.18 | 4.0E-5 | NA | |
26 | hsa-miR-27a-3p | CACNB2 | -0.37 | 0.00876 | -0.29 | 0.15115 | MirTarget; miRNATAP | -0.17 | 0.01799 | NA | |
27 | hsa-miR-27a-3p | CADM1 | -0.37 | 0.00876 | -0.03 | 0.88629 | MirTarget; miRNATAP | -0.39 | 0 | NA | |
28 | hsa-miR-27a-3p | CALM3 | -0.37 | 0.00876 | 0.21 | 0.01527 | miRNATAP | -0.1 | 0.00043 | NA | |
29 | hsa-miR-27a-3p | CCDC71 | -0.37 | 0.00876 | 0.07 | 0.37322 | MirTarget; miRNATAP | -0.1 | 9.0E-5 | NA | |
30 | hsa-miR-27a-3p | CCNC | -0.37 | 0.00876 | -0.3 | 0.00149 | MirTarget | -0.1 | 0.0015 | NA | |
31 | hsa-miR-27a-3p | CCNG1 | -0.37 | 0.00876 | -0.05 | 0.64033 | MirTarget; miRNATAP | -0.28 | 0 | NA | |
32 | hsa-miR-27a-3p | CCNY | -0.37 | 0.00876 | -0.02 | 0.71307 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
33 | hsa-miR-27a-3p | CDC14B | -0.37 | 0.00876 | -1.19 | 0 | miRNATAP | -0.28 | 1.0E-5 | NA | |
34 | hsa-miR-27a-3p | CHKA | -0.37 | 0.00876 | 1.03 | 0 | miRNATAP | -0.24 | 0 | NA | |
35 | hsa-miR-27a-3p | CLCN5 | -0.37 | 0.00876 | -0.78 | 0 | miRNATAP | -0.24 | 0 | NA | |
36 | hsa-miR-27a-3p | CLK2 | -0.37 | 0.00876 | 0.92 | 0 | miRNATAP | -0.1 | 0.00183 | NA | |
37 | hsa-miR-27a-3p | CPPED1 | -0.37 | 0.00876 | 0.16 | 0.18491 | MirTarget | -0.32 | 0 | NA | |
38 | hsa-miR-27a-3p | CTH | -0.37 | 0.00876 | -2.13 | 0 | MirTarget; miRNATAP | -0.53 | 0 | NA | |
39 | hsa-miR-27a-3p | CUL1 | -0.37 | 0.00876 | -0.12 | 0.10228 | miRNAWalker2 validate | -0.1 | 4.0E-5 | NA | |
40 | hsa-miR-27a-3p | CYTH1 | -0.37 | 0.00876 | 0.1 | 0.17383 | miRNATAP | -0.22 | 0 | NA | |
41 | hsa-miR-27a-3p | DCP2 | -0.37 | 0.00876 | 0.26 | 0.00123 | miRNATAP | -0.11 | 6.0E-5 | NA | |
42 | hsa-miR-27a-3p | DCUN1D4 | -0.37 | 0.00876 | -0.24 | 0.00352 | MirTarget; miRNATAP | -0.16 | 0 | NA | |
43 | hsa-miR-27a-3p | DNAJB9 | -0.37 | 0.00876 | -0.63 | 0 | miRNATAP | -0.19 | 2.0E-5 | NA | |
44 | hsa-miR-27a-3p | DVL2 | -0.37 | 0.00876 | 0.93 | 0 | miRNATAP | -0.1 | 0.00527 | NA | |
45 | hsa-miR-27a-3p | DYNLL2 | -0.37 | 0.00876 | -0.63 | 0 | MirTarget | -0.11 | 0.00507 | NA | |
46 | hsa-miR-27a-3p | EBF3 | -0.37 | 0.00876 | 1.74 | 0 | MirTarget; miRNATAP | -0.19 | 0.02249 | NA | |
47 | hsa-miR-27a-3p | EDEM3 | -0.37 | 0.00876 | 0.01 | 0.89915 | MirTarget; miRNATAP | -0.11 | 0.00394 | NA | |
48 | hsa-miR-27a-3p | EI24 | -0.37 | 0.00876 | -0.75 | 0 | miRNATAP | -0.12 | 0.00041 | NA | |
49 | hsa-miR-27a-3p | EIF5 | -0.37 | 0.00876 | -0.72 | 0 | MirTarget | -0.11 | 0.00044 | NA | |
50 | hsa-miR-27a-3p | ELL2 | -0.37 | 0.00876 | -0.77 | 0 | MirTarget; miRNATAP | -0.37 | 0 | NA | |
51 | hsa-miR-27a-3p | ELOVL6 | -0.37 | 0.00876 | -1.01 | 0 | mirMAP | -0.15 | 0.03932 | NA | |
52 | hsa-miR-27a-3p | ERP44 | -0.37 | 0.00876 | -0.19 | 0.01254 | mirMAP | -0.1 | 4.0E-5 | NA | |
53 | hsa-miR-27a-3p | EXOC8 | -0.37 | 0.00876 | 0.11 | 0.17333 | MirTarget | -0.11 | 9.0E-5 | NA | |
54 | hsa-miR-27a-3p | FAM120C | -0.37 | 0.00876 | -0.13 | 0.23093 | mirMAP; miRNATAP | -0.11 | 0.00529 | NA | |
55 | hsa-miR-27a-3p | FAM134C | -0.37 | 0.00876 | 0.11 | 0.21873 | MirTarget | -0.17 | 0 | NA | |
56 | hsa-miR-27a-3p | FAM172A | -0.37 | 0.00876 | 0.23 | 0.00597 | MirTarget | -0.1 | 0.00026 | NA | |
57 | hsa-miR-27a-3p | FAM184A | -0.37 | 0.00876 | -0.01 | 0.95662 | MirTarget | -0.62 | 0 | NA | |
58 | hsa-miR-27a-3p | FAM200B | -0.37 | 0.00876 | -0.06 | 0.51148 | MirTarget | -0.19 | 0 | NA | |
59 | hsa-miR-27a-3p | FASN | -0.37 | 0.00876 | 0.95 | 0 | miRNATAP | -0.37 | 0 | NA | |
60 | hsa-miR-27a-3p | FOXN3 | -0.37 | 0.00876 | -0.43 | 6.0E-5 | miRNATAP | -0.25 | 0 | NA | |
61 | hsa-miR-27a-3p | FOXO1 | -0.37 | 0.00876 | -1.85 | 0 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.12 | 0.03605 | 25897249; 25652374 | Adipose tissue secreted miR 27a promotes liver cancer by targeting FOXO1 in obese individuals;The expression of miR-27a and FOXO1 in AsPC-1 cells was determined by real-time RT-PCR and Western blot respectively; Both GSPE and miR-27a inhibitor alone could up-regulate FOXO1 expression |
62 | hsa-miR-27a-3p | FOXP4 | -0.37 | 0.00876 | 0.4 | 7.0E-5 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.12 | 0.0009 | NA | |
63 | hsa-miR-27a-3p | FUBP3 | -0.37 | 0.00876 | -0.38 | 0 | miRNATAP | -0.11 | 0.00023 | NA | |
64 | hsa-miR-27a-3p | GFOD1 | -0.37 | 0.00876 | -0.74 | 0 | MirTarget | -0.14 | 0.01018 | NA | |
65 | hsa-miR-27a-3p | GLYATL1 | -0.37 | 0.00876 | -3.18 | 0 | MirTarget | -0.54 | 6.0E-5 | NA | |
66 | hsa-miR-27a-3p | GPAM | -0.37 | 0.00876 | -0.47 | 0.0638 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.67 | 0 | NA | |
67 | hsa-miR-27a-3p | GPT2 | -0.37 | 0.00876 | -1.48 | 0 | miRNAWalker2 validate; mirMAP | -0.38 | 1.0E-5 | NA | |
68 | hsa-miR-27a-3p | HIPK2 | -0.37 | 0.00876 | -0.24 | 0.08389 | miRNAWalker2 validate; miRNATAP | -0.2 | 2.0E-5 | 20646448; 20624637 | 2 A2780/Taxol cells transfection with inhibitors of miR-27a showed that the levels of MDR1 mRNA was decreased by 39% P-gp protein level 26+/-5% decreased than that in the NC group 43+/-7% HIPK2 protein level 30+/-6% increased than that in the NC group 19+/-4% the 50% inhibition concentration 0.5 micromol/L was less than that in the NC group 6.8 micromol/L apoptosis rate 32.5+/-3.6% was higher than that in the NC group 5.6+/-2.1% and there were significant differences between two groups all P<0.05; The expression of miR-27a is upregulated in A2780/Taxol cells which may regulate MDR1 and P-gp expression by targeting HIPK2;MiR 27a modulates MDR1/P glycoprotein expression by targeting HIPK2 in human ovarian cancer cells; Transfection of A2780/Taxol cells with the inhibitors of miR-27a decreased the expression of MDR1 mRNA and P-gp protein increased HIPK2 protein expression enhanced the sensitivity of A2780/taxol cells to paclitaxel increased paclitaxel-induced apoptosis and the fluorescence intensity of intracellular Rh-123; The deregulation of miR-27a may be involved in the development of drug resistance regulating the expression of MDR1/P-gp at least in part by targeting HIPK2 in ovarian cancer cells |
69 | hsa-miR-27a-3p | HMGCR | -0.37 | 0.00876 | -0.03 | 0.86086 | miRNATAP | -0.37 | 0 | NA | |
70 | hsa-miR-27a-3p | HORMAD2 | -0.37 | 0.00876 | -2.21 | 0 | MirTarget; miRNATAP | -0.33 | 0.02252 | NA | |
71 | hsa-miR-27a-3p | HSPD1 | -0.37 | 0.00876 | 0.07 | 0.42182 | MirTarget | -0.14 | 0 | NA | |
72 | hsa-miR-27a-3p | IMPA1 | -0.37 | 0.00876 | 0.15 | 0.15162 | miRNAWalker2 validate | -0.14 | 6.0E-5 | NA | |
73 | hsa-miR-27a-3p | ING5 | -0.37 | 0.00876 | 0.67 | 0 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
74 | hsa-miR-27a-3p | INSR | -0.37 | 0.00876 | -0.28 | 0.00786 | miRNATAP | -0.13 | 0.00032 | NA | |
75 | hsa-miR-27a-3p | IPO9 | -0.37 | 0.00876 | 0.7 | 0 | mirMAP | -0.13 | 1.0E-5 | NA | |
76 | hsa-miR-27a-3p | IQGAP2 | -0.37 | 0.00876 | -1.1 | 0 | MirTarget | -0.4 | 0 | NA | |
77 | hsa-miR-27a-3p | IRS1 | -0.37 | 0.00876 | -0.22 | 0.13754 | MirTarget; miRNATAP | -0.49 | 0 | NA | |
78 | hsa-miR-27a-3p | KCTD21 | -0.37 | 0.00876 | -0.19 | 0.06162 | miRNATAP | -0.19 | 0 | NA | |
79 | hsa-miR-27a-3p | KHSRP | -0.37 | 0.00876 | 0.31 | 2.0E-5 | miRNATAP | -0.11 | 2.0E-5 | NA | |
80 | hsa-miR-27a-3p | KLF12 | -0.37 | 0.00876 | -0.86 | 0 | mirMAP | -0.4 | 0 | NA | |
81 | hsa-miR-27a-3p | KLF3 | -0.37 | 0.00876 | -0.61 | 0 | miRNATAP | -0.1 | 0.00033 | NA | |
82 | hsa-miR-27a-3p | KLHDC3 | -0.37 | 0.00876 | 0.39 | 0.0001 | miRNATAP | -0.23 | 0 | NA | |
83 | hsa-miR-27a-3p | KLHL31 | -0.37 | 0.00876 | 1.27 | 0 | MirTarget | -0.2 | 0.00255 | NA | |
84 | hsa-miR-27a-3p | LARP4 | -0.37 | 0.00876 | -0.61 | 0 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
85 | hsa-miR-27a-3p | LIPT2 | -0.37 | 0.00876 | -0.01 | 0.92161 | MirTarget | -0.11 | 0.00972 | NA | |
86 | hsa-miR-27a-3p | LPIN1 | -0.37 | 0.00876 | -0.14 | 0.37055 | miRNATAP | -0.22 | 2.0E-5 | NA | |
87 | hsa-miR-27a-3p | LRRC58 | -0.37 | 0.00876 | -0.04 | 0.75979 | mirMAP | -0.14 | 0.0003 | NA | |
88 | hsa-miR-27a-3p | LSM11 | -0.37 | 0.00876 | 0.76 | 0 | mirMAP | -0.24 | 0 | NA | |
89 | hsa-miR-27a-3p | LYSMD3 | -0.37 | 0.00876 | -0.5 | 0 | miRNAWalker2 validate | -0.11 | 0.00336 | NA | |
90 | hsa-miR-27a-3p | MAD2L1BP | -0.37 | 0.00876 | 0.17 | 0.04111 | MirTarget | -0.13 | 0 | NA | |
91 | hsa-miR-27a-3p | MAGI3 | -0.37 | 0.00876 | -0.59 | 0 | MirTarget; miRNATAP | -0.17 | 0.00012 | NA | |
92 | hsa-miR-27a-3p | MANEAL | -0.37 | 0.00876 | 0.6 | 0.00094 | miRNATAP | -0.32 | 0 | NA | |
93 | hsa-miR-27a-3p | MAP3K13 | -0.37 | 0.00876 | -0.45 | 0.05753 | MirTarget | -0.18 | 0.0253 | NA | |
94 | hsa-miR-27a-3p | MAPK14 | -0.37 | 0.00876 | -0.14 | 0.04955 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
95 | hsa-miR-27a-3p | MBTD1 | -0.37 | 0.00876 | -0.15 | 0.10862 | miRNAWalker2 validate | -0.18 | 0 | NA | |
96 | hsa-miR-27a-3p | MED13 | -0.37 | 0.00876 | -0.26 | 0.00586 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
97 | hsa-miR-27a-3p | MEPCE | -0.37 | 0.00876 | 0.26 | 0.00176 | miRNATAP | -0.16 | 0 | NA | |
98 | hsa-miR-27a-3p | MIER3 | -0.37 | 0.00876 | -0.29 | 0.00044 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.14 | 0 | NA | |
99 | hsa-miR-27a-3p | MOCS1 | -0.37 | 0.00876 | -0.56 | 3.0E-5 | mirMAP | -0.34 | 0 | NA | |
100 | hsa-miR-27a-3p | MOCS3 | -0.37 | 0.00876 | 0.06 | 0.43529 | MirTarget | -0.19 | 0 | NA | |
101 | hsa-miR-27a-3p | MOSPD3 | -0.37 | 0.00876 | 0.26 | 0.01944 | miRNATAP | -0.18 | 0 | NA | |
102 | hsa-miR-27a-3p | MREG | -0.37 | 0.00876 | 0.47 | 0.00032 | MirTarget | -0.17 | 0.00014 | NA | |
103 | hsa-miR-27a-3p | MRPS14 | -0.37 | 0.00876 | 0.43 | 0 | miRNATAP | -0.15 | 0 | NA | |
104 | hsa-miR-27a-3p | MRPS25 | -0.37 | 0.00876 | 0.02 | 0.84026 | MirTarget | -0.14 | 1.0E-5 | NA | |
105 | hsa-miR-27a-3p | MTMR4 | -0.37 | 0.00876 | -0.2 | 0.11072 | miRNATAP | -0.37 | 0 | NA | |
106 | hsa-miR-27a-3p | NDUFS4 | -0.37 | 0.00876 | 0.14 | 0.21443 | MirTarget | -0.17 | 1.0E-5 | NA | |
107 | hsa-miR-27a-3p | NEDD4 | -0.37 | 0.00876 | -0.21 | 0.20967 | MirTarget; miRNATAP | -0.38 | 0 | NA | |
108 | hsa-miR-27a-3p | NFIA | -0.37 | 0.00876 | -0.92 | 0 | mirMAP; miRNATAP | -0.19 | 2.0E-5 | NA | |
109 | hsa-miR-27a-3p | NLK | -0.37 | 0.00876 | 0.22 | 0.00116 | miRNATAP | -0.15 | 0 | NA | |
110 | hsa-miR-27a-3p | NR1D2 | -0.37 | 0.00876 | -0.43 | 4.0E-5 | miRNATAP | -0.14 | 0.00011 | NA | |
111 | hsa-miR-27a-3p | NR5A2 | -0.37 | 0.00876 | -0.7 | 0.00021 | miRNATAP | -0.16 | 0.01488 | NA | |
112 | hsa-miR-27a-3p | NRIP1 | -0.37 | 0.00876 | -0.83 | 0 | MirTarget; miRNATAP | -0.13 | 0.00088 | NA | |
113 | hsa-miR-27a-3p | NSA2 | -0.37 | 0.00876 | 0.15 | 0.0763 | MirTarget | -0.17 | 0 | NA | |
114 | hsa-miR-27a-3p | NXT2 | -0.37 | 0.00876 | 0.28 | 0.01042 | MirTarget; miRNATAP | -0.14 | 0.00031 | NA | |
115 | hsa-miR-27a-3p | OAF | -0.37 | 0.00876 | -1.07 | 0 | MirTarget | -0.23 | 0 | NA | |
116 | hsa-miR-27a-3p | ONECUT2 | -0.37 | 0.00876 | 0.12 | 0.55138 | miRNATAP | -0.49 | 0 | NA | |
117 | hsa-miR-27a-3p | PAIP2 | -0.37 | 0.00876 | 0.06 | 0.39477 | MirTarget | -0.14 | 0 | NA | |
118 | hsa-miR-27a-3p | PALM2 | -0.37 | 0.00876 | -2.08 | 0 | MirTarget | -0.18 | 0.03311 | NA | |
119 | hsa-miR-27a-3p | PANK1 | -0.37 | 0.00876 | -1.79 | 0 | miRNATAP | -0.37 | 0 | NA | |
120 | hsa-miR-27a-3p | PAQR9 | -0.37 | 0.00876 | 0.14 | 0.51216 | MirTarget | -0.54 | 0 | NA | |
121 | hsa-miR-27a-3p | PATZ1 | -0.37 | 0.00876 | 0.09 | 0.32877 | miRNATAP | -0.15 | 0 | NA | |
122 | hsa-miR-27a-3p | PDE3B | -0.37 | 0.00876 | -0.99 | 0 | MirTarget | -0.33 | 0 | NA | |
123 | hsa-miR-27a-3p | PDHX | -0.37 | 0.00876 | -0.36 | 0 | MirTarget; miRNATAP | -0.16 | 0 | NA | |
124 | hsa-miR-27a-3p | PDIA5 | -0.37 | 0.00876 | -0.87 | 0 | MirTarget; miRNATAP | -0.11 | 0.00814 | NA | |
125 | hsa-miR-27a-3p | PDK4 | -0.37 | 0.00876 | -2.11 | 0 | MirTarget | -0.4 | 6.0E-5 | NA | |
126 | hsa-miR-27a-3p | PDPK1 | -0.37 | 0.00876 | 0.31 | 0.01459 | miRNATAP | -0.13 | 0.00358 | NA | |
127 | hsa-miR-27a-3p | PEG10 | -0.37 | 0.00876 | 1.32 | 0.03061 | MirTarget | -0.84 | 6.0E-5 | NA | |
128 | hsa-miR-27a-3p | PGAP1 | -0.37 | 0.00876 | 0.01 | 0.92638 | miRNATAP | -0.11 | 0.01339 | NA | |
129 | hsa-miR-27a-3p | PHB | -0.37 | 0.00876 | 0.23 | 0.01203 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 6.0E-5 | 22505583 | Androgen regulated processing of the oncomir miR 27a which targets Prohibitin in prostate cancer; Increasing miR-27a expression results in reduced PHB mRNA and protein levels and increased expression of AR target genes and prostate cancer cell growth |
130 | hsa-miR-27a-3p | PIP4K2B | -0.37 | 0.00876 | 0.58 | 0 | mirMAP | -0.11 | 6.0E-5 | NA | |
131 | hsa-miR-27a-3p | PITPNM2 | -0.37 | 0.00876 | 0.25 | 0.07997 | miRNATAP | -0.17 | 0.00051 | NA | |
132 | hsa-miR-27a-3p | PJA2 | -0.37 | 0.00876 | -0.55 | 0 | miRNAWalker2 validate | -0.11 | 0.00103 | NA | |
133 | hsa-miR-27a-3p | PPARA | -0.37 | 0.00876 | -0.61 | 3.0E-5 | MirTarget; miRNATAP | -0.4 | 0 | NA | |
134 | hsa-miR-27a-3p | PPARG | -0.37 | 0.00876 | 0.33 | 0.04066 | MirTarget; miRNATAP | -0.28 | 0 | NA | |
135 | hsa-miR-27a-3p | PPP3R1 | -0.37 | 0.00876 | -0.35 | 0 | miRNATAP | -0.12 | 0 | NA | |
136 | hsa-miR-27a-3p | PTAR1 | -0.37 | 0.00876 | -0.3 | 0.00286 | MirTarget | -0.13 | 0.00027 | NA | |
137 | hsa-miR-27a-3p | RAP2C | -0.37 | 0.00876 | -0.41 | 9.0E-5 | miRNATAP | -0.16 | 1.0E-5 | NA | |
138 | hsa-miR-27a-3p | RGPD5 | -0.37 | 0.00876 | -0.38 | 0.20276 | MirTarget | -0.27 | 0.00996 | NA | |
139 | hsa-miR-27a-3p | RMND5A | -0.37 | 0.00876 | -0.49 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.27 | 0 | NA | |
140 | hsa-miR-27a-3p | RORA | -0.37 | 0.00876 | -1.19 | 0 | mirMAP; miRNATAP | -0.3 | 0 | NA | |
141 | hsa-miR-27a-3p | RPL19 | -0.37 | 0.00876 | 0.34 | 0.00137 | miRNAWalker2 validate | -0.1 | 0.00514 | NA | |
142 | hsa-miR-27a-3p | RPS18 | -0.37 | 0.00876 | 0.5 | 5.0E-5 | miRNAWalker2 validate | -0.15 | 0.00049 | NA | |
143 | hsa-miR-27a-3p | RPS24 | -0.37 | 0.00876 | 0.27 | 0.0468 | miRNAWalker2 validate | -0.1 | 0.02967 | NA | |
144 | hsa-miR-27a-3p | RPS6KB1 | -0.37 | 0.00876 | 0.04 | 0.57907 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
145 | hsa-miR-27a-3p | RPTOR | -0.37 | 0.00876 | 0.68 | 0 | miRNAWalker2 validate | -0.13 | 1.0E-5 | NA | |
146 | hsa-miR-27a-3p | RREB1 | -0.37 | 0.00876 | -0.27 | 0.09406 | miRNATAP | -0.17 | 0.00186 | NA | |
147 | hsa-miR-27a-3p | RYBP | -0.37 | 0.00876 | -0.69 | 0 | MirTarget | -0.15 | 0 | NA | |
148 | hsa-miR-27a-3p | SAP30BP | -0.37 | 0.00876 | 0.37 | 0 | miRNATAP | -0.1 | 0.00027 | NA | |
149 | hsa-miR-27a-3p | SATB2 | -0.37 | 0.00876 | 0.52 | 0.00119 | MirTarget; miRNATAP | -0.14 | 0.00952 | NA | |
150 | hsa-miR-27a-3p | SBF2 | -0.37 | 0.00876 | -0.14 | 0.24837 | MirTarget | -0.12 | 0.00761 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 47 | 1805 | 6.326e-09 | 2.943e-05 |
2 | STEROID HORMONE MEDIATED SIGNALING PATHWAY | 11 | 125 | 9.909e-08 | 0.0002305 |
3 | POSITIVE REGULATION OF GENE EXPRESSION | 42 | 1733 | 3.491e-07 | 0.0005412 |
4 | RESPONSE TO ENDOGENOUS STIMULUS | 37 | 1450 | 5.816e-07 | 0.0005412 |
5 | CELLULAR RESPONSE TO HORMONE STIMULUS | 21 | 552 | 5.032e-07 | 0.0005412 |
6 | HORMONE MEDIATED SIGNALING PATHWAY | 11 | 158 | 1.058e-06 | 0.0008202 |
7 | RESPONSE TO INSULIN | 12 | 205 | 2.139e-06 | 0.001244 |
8 | INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 11 | 168 | 1.935e-06 | 0.001244 |
9 | CELLULAR RESPONSE TO INSULIN STIMULUS | 10 | 146 | 3.818e-06 | 0.001882 |
10 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 12 | 218 | 4.044e-06 | 0.001882 |
11 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 22 | 724 | 1.036e-05 | 0.004383 |
12 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 22 | 740 | 1.454e-05 | 0.005636 |
13 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 26 | 1008 | 2.794e-05 | 0.009286 |
14 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 38 | 1784 | 2.772e-05 | 0.009286 |
15 | RESPONSE TO HORMONE | 24 | 893 | 3.033e-05 | 0.009409 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | STEROID HORMONE RECEPTOR ACTIVITY | 7 | 59 | 3.003e-06 | 0.00279 |
2 | ENZYME BINDING | 39 | 1737 | 6.323e-06 | 0.002937 |
3 | TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING | 6 | 48 | 1.149e-05 | 0.003559 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 27 | 1005 | 9.371e-06 | 0.005473 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | AMPK_signaling_pathway_hsa04152 | 9 | 121 | 5.999e-06 | 0.0003119 | |
2 | FoxO_signaling_pathway_hsa04068 | 8 | 132 | 8.631e-05 | 0.002244 | |
3 | mTOR_signaling_pathway_hsa04150 | 8 | 151 | 0.0002191 | 0.003797 | |
4 | Autophagy_animal_hsa04140 | 5 | 128 | 0.01203 | 0.1564 | |
5 | Phosphatidylinositol_signaling_system_hsa04070 | 4 | 99 | 0.02147 | 0.2233 | |
6 | Cellular_senescence_hsa04218 | 5 | 160 | 0.02851 | 0.2269 | |
7 | cGMP_PKG_signaling_pathway_hsa04022 | 5 | 163 | 0.03054 | 0.2269 | |
8 | MAPK_signaling_pathway_hsa04010 | 7 | 295 | 0.03908 | 0.254 | |
9 | Rap1_signaling_pathway_hsa04015 | 5 | 206 | 0.06979 | 0.3356 | |
10 | Phospholipase_D_signaling_pathway_hsa04072 | 4 | 146 | 0.07099 | 0.3356 | |
11 | Wnt_signaling_pathway_hsa04310 | 4 | 146 | 0.07099 | 0.3356 | |
12 | VEGF_signaling_pathway_hsa04370 | 2 | 59 | 0.1305 | 0.4374 | |
13 | Sphingolipid_signaling_pathway_hsa04071 | 3 | 118 | 0.1316 | 0.4374 | |
14 | Cell_cycle_hsa04110 | 3 | 124 | 0.1463 | 0.4374 | |
15 | Oocyte_meiosis_hsa04114 | 3 | 124 | 0.1463 | 0.4374 | |
16 | cAMP_signaling_pathway_hsa04024 | 4 | 198 | 0.1612 | 0.4374 | |
17 | p53_signaling_pathway_hsa04115 | 2 | 68 | 0.1636 | 0.4374 | |
18 | PI3K_Akt_signaling_pathway_hsa04151 | 6 | 352 | 0.1743 | 0.4374 | |
19 | Adherens_junction_hsa04520 | 2 | 72 | 0.1787 | 0.4374 | |
20 | Apelin_signaling_pathway_hsa04371 | 3 | 137 | 0.1798 | 0.4374 | |
21 | Regulation_of_actin_cytoskeleton_hsa04810 | 4 | 208 | 0.182 | 0.4374 | |
22 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 3 | 139 | 0.1851 | 0.4374 | |
23 | Cell_adhesion_molecules_.CAMs._hsa04514 | 3 | 145 | 0.2013 | 0.4551 | |
24 | TGF_beta_signaling_pathway_hsa04350 | 2 | 84 | 0.2252 | 0.4767 | |
25 | ErbB_signaling_pathway_hsa04012 | 2 | 85 | 0.2292 | 0.4767 | |
26 | Endocytosis_hsa04144 | 4 | 244 | 0.2627 | 0.5253 | |
27 | HIF_1_signaling_pathway_hsa04066 | 2 | 100 | 0.2883 | 0.5391 | |
28 | TNF_signaling_pathway_hsa04668 | 2 | 108 | 0.3197 | 0.5733 | |
29 | Focal_adhesion_hsa04510 | 3 | 199 | 0.3559 | 0.6169 | |
30 | Ras_signaling_pathway_hsa04014 | 3 | 232 | 0.45 | 0.6883 | |
31 | Tight_junction_hsa04530 | 2 | 170 | 0.5426 | 0.8061 | |
32 | Calcium_signaling_pathway_hsa04020 | 2 | 182 | 0.5796 | 0.8372 |